About this event

  • Date and time Mon 1 Feb 2021 from 12:00pm to 5:00pm
  • Location Online
  • Organised by Vascular, Lipid and Metabolic Medicine Section

This live stream will provide an update on pharmacotherapy treatments that have recently become available, or are in late-stage development for the prevention and treatment of cardiovascular disease. The assessment of cardiovascular risk and optimal application of these therapies will be discussed as well.

The updates will be given by highly respected clinical researchers and thought leaders who are recognised as experts in their fields.

The lectures will be clinically focused with the aim of educating healthcare professionals about these new therapies in the prevention and treatment of cardiovascular disease.

If you would like to attend the in-person event at the RSM 1 Wimpole street building (limited capacity) please book the in-person event here

Topics to be covered:

  • New pharmacotherapy treatments for the prevention and treatment of cardiovascular disease
  • The use of new pharmacotherapy treatments in the context of current treatment strategies and where they will fit into existing clinical guidelines
  • Improve matching of therapy to individual cardiovascular risk profiles according to the principles of precision medicine

Join in the conversation online using #RSMLive
Follow us on Twitter: @RoySocMed


Standard pricing available until 01 February 2021.


RSM Member RSM Trainee RSM Student
£10.00 £5.00 £5.00

Non - Member

Non - Member Trainee Student
£20.00 £15.00 £15.00


View the programme

Live stream begins

Professor Andrew Krentz, University of Reading and King’s College London

Evolution of cardiovascular risk management: a clinical perspective

Dr Alan Rees, HEART UK

LDL-cholesterol lowering drugs: Recent advances and novel therapies

Professor Kausik Ray, Imperial College, London

Triglycerides – A re-emerging target in atherosclerotic cardiovascular disease prevention and microvascular complications of obesity and diabetes

Dr Handrean Soran, University of Manchester

Lipoprotein(a): Emerging from the shadows?

Dr Jai Cegla, Imperial College

Panel discussion
Comfort Break
What should be the goal of cholesterol-lowering treatment? A quantitative evaluation

Professor Paul Durrington, University Manchester

Managing atherosclerotic cardiovascular disease: How close are we to precision risk assessment and individualizing treatment?

Professor Brian Ference, University of Cambridge

Myocardial metabolism: New cardioprotective drugs

Dr James Hobkirk, University of Hull

Panel discussion
Close of the live stream



Man searching computer

Join the RSM and get unlimited digital learning and e-resources access

The RSM has an extensive digital learning and online e-resources platform. As a member you'll enjoy unlimited digital learning any time you need and access to e-journals, e-books and 7 huge medical databases to support your clinical decision-making and research.

Our e-resources are updated continuously to ensure you receive the cutting edge knowledge you need. 


Become a member